Search

everythinglearnresearchcommunity

for

Search:↓

Disrupting the Flcn gene in mice causes early kidney cysts and tumors, which can be treated with rapamycin.

COVID-19 can cause various skin issues, like rashes and lesions, which are more common in younger patients and can be linked to more severe complications.

COVID-19 can cause temporary hair loss, often starting around 7-8 weeks after recovery, with factors like Vitamin D deficiency, other diseases, medication, and stress potentially contributing.

Monocytes might be linked to hair loss after COVID-19.

Low levels of vitamin B12 and ferritin are linked to early hair graying.

The study identified five types of long COVID symptoms and suggests tailored management strategies for each.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

Androgenetic alopecia in men is genetic and linked to health issues like obesity and heart disease, with treatments including minoxidil, finasteride, and hair transplants.

Biotinidase deficiency has various symptoms and can be treated with biotin supplements.

Children under 10 can experience hair thinning without hormone issues, and it may improve with treatment.

Birth control pills and cyproterone acetate can help treat acne in women, especially when linked to hormonal issues.

Over 50% of women over 50 experience hair loss, with minoxidil being the only proven effective treatment.

The therapies improved ejaculation disorders and sexual function in middle-aged men.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

Early detection and intensive treatment of diseases caused by Staphylococcus aureus toxins are crucial for reducing severe health effects.

Eosinophilia-myalgia syndrome, linked to contaminated L-tryptophan supplements, caused severe symptoms and some deaths, with long-term effects in survivors.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

Higher IL-17A levels indicate more severe alopecia areata.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

The paper concludes that the 1982 criteria for diagnosing systemic lupus erythematosus need updating to improve accuracy and involve dermatologists in the process.

The document concludes that specific itchy skin diseases during pregnancy have varying fetal risks and treatments, including corticosteroids and other medications.

Women with androgenic alopecia are more likely to have polycystic ovaries and higher androgen levels, which may indicate PCOS.

Inherited ichthyoses cause widespread skin scaling and thickening due to gene mutations.

Alopecia significantly lowers women's quality of life, with psychological and social challenges, highlighting the importance of early treatment and support.

Premature graying of hair may suggest health issues and currently lacks effective treatments.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.

Men with Kennedy disease have less chance of hair loss.

Treat hair loss with finasteride, minoxidil, or surgery; consider side effects and severity.

Testosterone replacement therapy can prevent men from fathering children and should not be used by those wanting to stay fertile.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.